Revance Therapeutics Inc (DELISTED) (RVNC:DL)

3.65 0.00 (0.00%) USD  |  NASDAQ  |  Feb 06, 16:00
More

Revance Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RVNC:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
BioAge Labs, Inc. --
Ligand Pharmaceuticals, Inc. Upgrade
Cellectar Biosciences, Inc. Upgrade
Hepion Pharmaceuticals, Inc. Upgrade